Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Notes Payables (2022)

Historic Notes Payables for CervoMed (CRVO) over the last 7 years, with Q4 2022 value amounting to $12.4 million.

  • CervoMed's Notes Payables changed N/A to $12.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $12.4 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2022, which is N/A changed from last year.
  • As of Q4 2022, CervoMed's Notes Payables stood at $12.4 million.
  • Over the past 5 years, CervoMed's Notes Payables peaked at $12.4 million during Q4 2022, and registered a low of $12.4 million during Q4 2022.